Cargando…
High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
PURPOSE: High-dose-rate (HDR) brachytherapy has been accepted as an effective and safe method to treat prostate cancer. The aim of this study was to describe acute toxicity following HDR brachytherapy to the prostate, and to examine the association between dosimetric parameters and urinary toxicity...
Autores principales: | Cendales, Ricardo, Alwers, Elizabeth, Cifuentes, Javier, Bobadilla, Ivan, Torres, Felipe, Arbelaez, Juan, Gaitan, Armando, Cortes, Helber, Acevedo, Yenny, Quintero, Paulo, Vasquez, Jaider |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371062/ https://www.ncbi.nlm.nih.gov/pubmed/25829931 http://dx.doi.org/10.5114/jcb.2015.48838 |
Ejemplares similares
-
IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
por: Cendales, Ricardo, et al.
Publicado: (2014) -
High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis
por: Anderson, Eric M., et al.
Publicado: (2021) -
A radiobiological study of the schemes with a low number of fractions in high-dose-rate brachytherapy as monotherapy for prostate cancer
por: Guirado, Damián, et al.
Publicado: (2020) -
The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013) -
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)